Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
PhoreMost is a biotech company headquartered in Cambridge, UK, focused on translating scientific breakthroughs into innovative anti-cancer drugs targeting unmet clinical needs. Its official website is used to display the company's information, development pipeline, and partnership opportunities to the public.
The website clearly discloses the company's core research pipeline: its lead project PMC-001 has advanced to Phase 1/2a clinical trials. It is an oral microtubule destabilizer that can cross the blood-brain barrier, developed to treat primary and metastatic brain cancer. Additionally, it lists early-stage projects including PMC-002 for HPV-positive cancers and PMC-003, a bifunctional degrader based on a novel E3 ligase. The site also hosts information for external R&D collaboration inquiries, and publishes the company's latest financing updates, team structure, and job openings.
As a biopharmaceutical company in the research and development stage, PhoreMost does not currently have any approved drugs available for sale to general consumers, and no pricing-related information is published on the website. It is positioned as an information platform for industry investors and pharma partnership prospects.
Pros: The website has a clear structure, with transparent and complete disclosure of pipeline, team, and development progress information. Navigation is simple and easy to use, and content is updated in a timely manner. Based at the Babraham Research Campus in Cambridge, the team has strong professional credentials, financing progress is clearly documented, and R&D advancement is well-ordered.
Cons: It is only targeted at B2B industry audiences, so it offers limited practical value for general users, and a Chinese language interface is not currently available.
This website is suitable for investors in the pharmaceutical industry, drug R&D institutions, potential partners, and job seekers to visit. Currently, the site can be accessed directly from within China, no VPN proxy is required.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on phoremost.com official site.
phoremost.com is an United Kingdom Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach phoremost.com directly.